Livagen
KEDA Tetrapeptide · Liver Bioregulator
Livagen is a Khavinson bioregulator tetrapeptide (KEDA) with significant hepatoprotective and immunomodulatory properties. Structurally similar to Epitalon, it normalizes immune and antioxidant status while restoring liver function in hepatitis conditions. Livagen is best known for its ability to decondense chromatin, activating silent genes including ribosomal genes to boost protein synthesis and cellular activity. Maximum protective effects occur during aging.
Overview
Livagen is a Khavinson bioregulator tetrapeptide (KEDA) with significant hepatoprotective and immunomodulatory properties. Structurally similar to Epitalon, it normalizes immune and antioxidant status while restoring liver function in hepatitis conditions. Livagen is best known for its ability to decondense chromatin, activating silent genes including ribosomal genes to boost protein synthesis and cellular activity. Maximum protective effects occur during aging.
Livagen works through direct effects on DNA structure and function. It decondenses chromatin (tightly packed DNA), increasing expression of certain genes and improving the 'youthful' profile of cells. The peptide activates multiple genes in lymphocytes, including previously silent ribosomal genes, boosting protein synthesis and cell activity. It exhibits hepatoprotective effects through normalizing immune and antioxidant status in liver tissue.
Research indications
What the compound has been studied for, grouped by body system. Effect size is the reported magnitude where it was measured — not a recommendation.
Protects liver tissue through normalizing immune and antioxidant status.
Restores liver functions in both acute and chronic hepatitis models.
Shows protective properties in liver fibroid induration models.
Decondenses chromatin to restore youthful gene expression patterns.
Maximum hepatoprotective effects occur during aging.
Activates silent genes including ribosomal genes for improved protein synthesis.
Normalizes immune function alongside liver protective effects.
A large effect in a weak study and a small effect in a strong one are different things. Effect size is never evidence of use in people.
- Class
- Tetrapeptide bioregulator
- Chain length
- 4 residues
- Molecular weight
- 432 Da
- Typical dose
- 10-20 mg daily
- Frequency
- Daily for 10-20 days per cycle
- Cycle length
- 10-20 days
- Storage
- Oral capsules: Room temperature. Injectable reconstituted: 2-8°C refrigerated
Molecular data
- Type
- Tetrapeptide bioregulator
- Molecular weight
- 432 Da
- Chain length
- 4 residues
KEDADosing reference
Doses reported in the literature and by suppliers. These are a record of what has been used in research — reference, never instruction.
| Context | Route | Amount | Frequency |
|---|---|---|---|
| Standard protocol | Oral capsules | 10-20 mg | Daily for 10-20 days |
| Maintenance | Oral capsules | 10 mg | 2-3 cycles yearly |
| Research protocol | IM or SubQ | 10 mg | Daily for 10 days |
Interactions
Structurally similar; often combined in comprehensive anti-aging protocols.
Both support liver function and antioxidant status.
Complementary liver bioregulators with different sequences.
Different organ targets; can be combined in bioregulator protocols.
Quality checklist
- ✓White powder or capsules
- ✓Clear solution if reconstituted
- ✓Proper packaging and labeling
- !Unknown source or purity
- ×Discoloration
- ×Unusual odor
- ×Damaged packaging
What to expect
Safety
- Generally well-tolerated
- Minimal side effects reported
- Allergic reactions
- Unusual liver symptoms
- Active liver emergencies (seek medical care)
- Known hypersensitivity
- Pregnancy or breastfeeding
FAQ
What does 'decondensing chromatin' actually do?
Chromatin decondensation refers to loosening tightly-packed DNA, making previously silent genes accessible for expression. Livagen activates this process, turning on genes related to protein synthesis and cellular function that typically decrease with age. This restores more youthful gene expression patterns.
Is Livagen the same as Epitalon?
No, though they're both Khavinson bioregulator tetrapeptides with similar structures. Livagen (KEDA) focuses on liver function and chromatin remodeling, while epitalon targets the pineal gland. They're often used together in comprehensive anti-aging protocols.
How do I know if Livagen is working?
Benefits from Livagen are subtle and build over weeks. Liver function markers (transaminases, bilirubin) may improve on blood work. Systemic effects include improved immune markers and energy. Results are assessed best through lab work and multi-week observation rather than immediate symptoms.
Can I take Livagen continuously or do I need to cycle?
Traditional protocols recommend 10-20 day cycles, 2-3 times per year with breaks between cycles. This allows chromatin changes and gene expression effects to take hold while avoiding potential adaptation. Continuous daily use hasn't been well-studied.